Nov. 17, 2021 |
|
April. 10, 2025 |
|
jRCT1052210122 |
A Multicenter, Randomized, Parallel-Group Study of the Efficacy and Safety of a Low Ablation Index Group versus a High Ablation Index Group during Extensive Encircling Pulmonary Vein Isolation for Atrial Fibrillation |
|
optimal ablation InDEx for Atrial fibriLlation during extensive encircling Pulmonary Vein Isolation study (IDEAL-PVI study) |
Shizuta Satoshi |
||
Kyoto University Hospital |
||
54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, Japan |
||
+81-75-751-4255 |
||
shizuta@kuhp.kyoto-u.ac.jp |
||
Nishiwaki Shushi |
||
Kyoto University Hospital |
||
54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, Japan |
||
+81-75-751-4255 |
||
s_nishiwaki@kuhp.kyoto-u.ac.jp |
Pending |
Nov. 17, 2021 |
||
200 | ||
Interventional |
||
randomized controlled trial |
||
single blind |
||
active control |
||
parallel assignment |
||
treatment purpose |
||
All of the following criteria should be met. |
||
Patients should be excluded if any of the following conditions apply |
||
20age old over | ||
85age old under | ||
Both |
||
Atrial fibrillation |
||
Low Ablation Index group |
||
Atrial fibrillation |
||
Catheter ablation |
||
D001281 |
||
D017115 |
||
Acute effects of expanded pulmonary vein isolation by High Ablation Index (successful isolation in one round of pulmonary vein energization, presence of reconduction after waiting, presence of dormant conduction by ATP administration)), safety evaluation (complications, procedure time, fluoroscopy time) |
||
Chronic phase effects of expanded pulmonary vein isolation by High Ablation Index (excluding the blanking period within 3 months after ablation, the rate of recurrent atrial arrhythmias lasting longer than 30 seconds at 12 months, status under antiarrhythmic medication, and changes in quality of life). |
Kyoto University Certified Review Board | |
Yoshida-konoe-cho, Sakyo-ku, Kyoto, Kyoto | |
+81-75-753-4680 |
|
ethcom@kuhp.kyoto-u.ac.jp | |
Approval | |
Oct. 11, 2021 |
none |